Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TriLastin looks to stretch distribution

This article was originally published in The Rose Sheet

Executive Summary

EC Research "hope[s] to have broader distribution" in 2008 for its TriLastin-SR stretch-mark cream, sales of which surged 60 percent in 2007 compared with the year before, the firm says. Introduced online in 2005, TriLastin-SR has "posted sales throughout 130 countries" and now is available at A Pea in the Pod and Destination Maternity. The product's success has been "fueled by personal testimonials and recommendations," according to EC Research President Greg Cellini. Formulated with "high-potency" elastin, collagen and soy protein, TriLastin-SR "helps to prevent the breakdown of dermal tissues that causes stretch marks but also provides the necessary proteins to help repair existing marks." Firm says product "normalizes" stretch marks via a two-phased delivery system in which "de-hydrated microspheres attract moisture and rehydrate in the epidermis while a virtual 'skin patch' of marine collagen protects the skin and delivers nourishing compounds." EC Research says it aspires to grow the Trilastin brand to address a range of dermal imperfections...
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS015177

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel